Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rare Cancer”

253 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 253 results

Testing effectiveness (Phase 2)Study completedNCT02923934
What this trial is testing

A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers

Who this might be right for
Gastrointestinal CancerNeuroendocrine TumoursMalignant Female Reproductive System Neoplasm
Olivia Newton-John Cancer Research Institute 120
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Not applicableStudy completedNCT00004832
What this trial is testing

Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome

Who this might be right for
Lambert-Eaton Myasthenic Syndrome
FDA Office of Orphan Products Development 26
Testing effectiveness (Phase 2)UnknownNCT05548348
What this trial is testing

First-line Furmonertinib in Advanced NSCLC Patients With EGFR Uncommon Mutation

Who this might be right for
Non-small Cell Lung CancerEGFR G719XEGFR L861Q+1 more
Chongqing University Cancer Hospital 30
Not applicableLooking for participantsNCT06573723
What this trial is testing

Institutional Registry of Rare Diseases

Who this might be right for
Rare DiseasesAmyloidosisSarcoidosis+23 more
Hospital Italiano de Buenos Aires 380
Not applicableStudy completedNCT00007046
What this trial is testing

Genetic Study of Patients and Families With Diaphyseal Medullary Stenosis With Malignant Fibrous Histiocytoma of the Bone

Who this might be right for
StenosisHistiocytoma
National Center for Research Resources (NCRR)
Not applicableLooking for participantsNCT06541652
What this trial is testing

A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers

Who this might be right for
HepatocholangiocarcinomaFibrolamellar CarcinomaHepatic Epithelioid Hemangioendothelioma+7 more
Federation Francophone de Cancerologie Digestive 150
Not applicableStudy completedNCT05126420
What this trial is testing

MIYOPERİCYTOMA OF ORAL MUCOSE: CASE REPORT

Who this might be right for
Myopericytoma
Ankara University 1
Not applicableStudy completedNCT00005104
What this trial is testing

Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary SyndromeHyperinsulinism
National Center for Research Resources (NCRR) 99
Early research (Phase 1)Study completedNCT01048892
What this trial is testing

Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features

Who this might be right for
Adrenocortical CarcinomaGastrointestinal Carcinoid TumorKidney Cancer+3 more
Children's Oncology Group 22
Not applicableLooking for participantsNCT05852522
What this trial is testing

Molecularly Aided Stratification for Tumor Eradication Research

Who this might be right for
Rare CancersMultiomics
German Cancer Research Center 10,000
Testing effectiveness (Phase 2)Looking for participantsNCT05168566
What this trial is testing

Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Teligene US 99
Testing effectiveness (Phase 2)Looking for participantsNCT06010329
What this trial is testing

Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Teligene US 66
Not applicableActive Not RecruitingNCT03857594
What this trial is testing

Integrative Sequencing In Germline and Hereditary Tumours

Who this might be right for
Hereditary Cancer SyndromeHigh-RiskMutation+1 more
University Health Network, Toronto 10
Large-scale testing (Phase 3)Looking for participantsNCT02305654
What this trial is testing

International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)

Who this might be right for
Squamous Cell Carcinoma of the Penis, Usual Type
Institute of Cancer Research, United Kingdom 200
Not applicableLooking for participantsNCT06856902
What this trial is testing

BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe

Who this might be right for
Cardiovascular DiseasesEndocrinologyInmunology+3 more
Technical University of Madrid 7,410
Testing effectiveness (Phase 2)Active Not RecruitingNCT03264131
What this trial is testing

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

Who this might be right for
LymphomaAdult T-Cell Leukemia/LymphomaLymphatic Diseases
UNC Lineberger Comprehensive Cancer Center 16
Not applicableLooking for participantsNCT01143454
What this trial is testing

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

Who this might be right for
Metabolic DiseaseObesityLi-Fraumeni Syndrome+3 more
National Heart, Lung, and Blood Institute (NHLBI) 5,000
Testing effectiveness (Phase 2)Study completedNCT01755195
What this trial is testing

Cabozantinib for Adults With Advanced Soft Tissue Sarcoma

Who this might be right for
Refractory Soft Tissue Sarcomas
National Cancer Institute (NCI) 55
Not applicableLooking for participantsNCT07147465
What this trial is testing

Performance Indicators and Impact on the Care Pathway of Sequencing on the SeqOIA and AURAGEN (Seqogen) Platforms for Oncology Patients

Who this might be right for
CancerNGSTumor+1 more
Assistance Publique - Hôpitaux de Paris 3,149
Load More Results